AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in… EP News Bureau Mar 24, 2025 In addition, AstraZeneca is launching a new joint venture with BioKangtai, to develop, manufacture, and commercialise innovative…
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine Reuters Nov 27, 2020 AstraZeneca shot developed with Oxford University is cheaper to make, easier to distribute and faster to scale up than its rivals